MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

The present invention relates to methods and assays for identifying agents capable of inhibiting the mutant huntingtin protein, inhibiting or reducing polyglutamine-induced protein aggregation, and/or altering huntingtin protein conformation, which inhibition is useful in the prevention, amelioratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FISCHER DAVID FREDERIK, JANSSEN RICHARD ANTONIUS JOZEF, VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA, DE PRIL REMKO, KWAK SEUNG, HOWLAND DAVID S, SIGNER ETHAN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FISCHER DAVID FREDERIK
JANSSEN RICHARD ANTONIUS JOZEF
VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA
DE PRIL REMKO
KWAK SEUNG
HOWLAND DAVID S
SIGNER ETHAN
description The present invention relates to methods and assays for identifying agents capable of inhibiting the mutant huntingtin protein, inhibiting or reducing polyglutamine-induced protein aggregation, and/or altering huntingtin protein conformation, which inhibition is useful in the prevention, amelioration and/or treatment of neurodegenerative diseases, and protein aggregation diseases more generally. In particular, the present invention provides methods and assays for identifying agents for use in the prevention and/or treatment of Huntington's disease. The invention provides polypeptide and nucleic acid TARGETs and siRNA sequences based on these
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2011077283A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2011077283A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2011077283A13</originalsourceid><addsrcrecordid>eNqNirsKwkAQANNYiPoPC7YR8ihiu-Q2yUHuTm73BKsQ5KxEA7Hw85XgB1gNM8w6eRvXUx169CDoWxIGtApqZ04uWMXpooakc4pBHGhFVnRzAekIGA2lEJia0IO2SxNPKOY7gWvAUvBOUUuWPIo-EyjNhEy8TVa38T7H3Y-bZN-Q1N0hTs8hztN4jY_4GgIXWZ5nVVUcS8zL_64PX-I6wQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES</title><source>esp@cenet</source><creator>FISCHER DAVID FREDERIK ; JANSSEN RICHARD ANTONIUS JOZEF ; VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA ; DE PRIL REMKO ; KWAK SEUNG ; HOWLAND DAVID S ; SIGNER ETHAN</creator><creatorcontrib>FISCHER DAVID FREDERIK ; JANSSEN RICHARD ANTONIUS JOZEF ; VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA ; DE PRIL REMKO ; KWAK SEUNG ; HOWLAND DAVID S ; SIGNER ETHAN</creatorcontrib><description>The present invention relates to methods and assays for identifying agents capable of inhibiting the mutant huntingtin protein, inhibiting or reducing polyglutamine-induced protein aggregation, and/or altering huntingtin protein conformation, which inhibition is useful in the prevention, amelioration and/or treatment of neurodegenerative diseases, and protein aggregation diseases more generally. In particular, the present invention provides methods and assays for identifying agents for use in the prevention and/or treatment of Huntington's disease. The invention provides polypeptide and nucleic acid TARGETs and siRNA sequences based on these</description><language>eng</language><subject>CHEMISTRY ; COMBINATORIAL CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICOLIBRARIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS ; TESTING</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110331&amp;DB=EPODOC&amp;CC=US&amp;NR=2011077283A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110331&amp;DB=EPODOC&amp;CC=US&amp;NR=2011077283A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FISCHER DAVID FREDERIK</creatorcontrib><creatorcontrib>JANSSEN RICHARD ANTONIUS JOZEF</creatorcontrib><creatorcontrib>VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA</creatorcontrib><creatorcontrib>DE PRIL REMKO</creatorcontrib><creatorcontrib>KWAK SEUNG</creatorcontrib><creatorcontrib>HOWLAND DAVID S</creatorcontrib><creatorcontrib>SIGNER ETHAN</creatorcontrib><title>MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES</title><description>The present invention relates to methods and assays for identifying agents capable of inhibiting the mutant huntingtin protein, inhibiting or reducing polyglutamine-induced protein aggregation, and/or altering huntingtin protein conformation, which inhibition is useful in the prevention, amelioration and/or treatment of neurodegenerative diseases, and protein aggregation diseases more generally. In particular, the present invention provides methods and assays for identifying agents for use in the prevention and/or treatment of Huntington's disease. The invention provides polypeptide and nucleic acid TARGETs and siRNA sequences based on these</description><subject>CHEMISTRY</subject><subject>COMBINATORIAL CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICOLIBRARIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirsKwkAQANNYiPoPC7YR8ihiu-Q2yUHuTm73BKsQ5KxEA7Hw85XgB1gNM8w6eRvXUx169CDoWxIGtApqZ04uWMXpooakc4pBHGhFVnRzAekIGA2lEJia0IO2SxNPKOY7gWvAUvBOUUuWPIo-EyjNhEy8TVa38T7H3Y-bZN-Q1N0hTs8hztN4jY_4GgIXWZ5nVVUcS8zL_64PX-I6wQ</recordid><startdate>20110331</startdate><enddate>20110331</enddate><creator>FISCHER DAVID FREDERIK</creator><creator>JANSSEN RICHARD ANTONIUS JOZEF</creator><creator>VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA</creator><creator>DE PRIL REMKO</creator><creator>KWAK SEUNG</creator><creator>HOWLAND DAVID S</creator><creator>SIGNER ETHAN</creator><scope>EVB</scope></search><sort><creationdate>20110331</creationdate><title>MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES</title><author>FISCHER DAVID FREDERIK ; JANSSEN RICHARD ANTONIUS JOZEF ; VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA ; DE PRIL REMKO ; KWAK SEUNG ; HOWLAND DAVID S ; SIGNER ETHAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2011077283A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>COMBINATORIAL CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICOLIBRARIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>FISCHER DAVID FREDERIK</creatorcontrib><creatorcontrib>JANSSEN RICHARD ANTONIUS JOZEF</creatorcontrib><creatorcontrib>VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA</creatorcontrib><creatorcontrib>DE PRIL REMKO</creatorcontrib><creatorcontrib>KWAK SEUNG</creatorcontrib><creatorcontrib>HOWLAND DAVID S</creatorcontrib><creatorcontrib>SIGNER ETHAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FISCHER DAVID FREDERIK</au><au>JANSSEN RICHARD ANTONIUS JOZEF</au><au>VAN STEENHOVEN DESIRE MARIA PETRONELLA CATHARINA</au><au>DE PRIL REMKO</au><au>KWAK SEUNG</au><au>HOWLAND DAVID S</au><au>SIGNER ETHAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES</title><date>2011-03-31</date><risdate>2011</risdate><abstract>The present invention relates to methods and assays for identifying agents capable of inhibiting the mutant huntingtin protein, inhibiting or reducing polyglutamine-induced protein aggregation, and/or altering huntingtin protein conformation, which inhibition is useful in the prevention, amelioration and/or treatment of neurodegenerative diseases, and protein aggregation diseases more generally. In particular, the present invention provides methods and assays for identifying agents for use in the prevention and/or treatment of Huntington's disease. The invention provides polypeptide and nucleic acid TARGETs and siRNA sequences based on these</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2011077283A1
source esp@cenet
subjects CHEMISTRY
COMBINATORIAL CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICOLIBRARIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
TESTING
title MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T12%3A48%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FISCHER%20DAVID%20FREDERIK&rft.date=2011-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2011077283A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true